Simplex Trading
APTO

Simplex Trading’s Aptose Biosciences, Inc. APTO Stock Holding History

Simplex Trading’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10
Closed -$2.69K – 10906
2022
Q3 		$2K Buy
10
+1
+11% +$345 ﹤0.01% 9447
2022
Q2 		$2K Sell
9
-4
-31% -$1.91K ﹤0.01% 9482
2022
Q1 		$8K Buy
13
+9
+225% +$4.98K ﹤0.01% 9128
2021
Q4 		$2K Sell
4
-42
-91% -$39.5K ﹤0.01% 10105
2021
Q3 		$70K Buy
46
+2
+5% +$2.5K ﹤0.01% 7095
2021
Q2 		$66K Sell
44
-113
-72% -$246K ﹤0.01% 7297
2021
Q1 		$423K Buy
157
+114
+265% +$226K ﹤0.01% 3620
2020
Q4 		$0 Buy
43
+33
+330% +$77.5K ﹤0.01% 9313
2020
Q3 		$0 Sell
10
-2
-17% -$4.99K ﹤0.01% 8750
2020
Q2 		$0 Sell
12
-53
-82% -$171K ﹤0.01% 8610
2020
Q1 		$173K Buy
+65
New +$194K ﹤0.01% 3763
2019
Q4 		– Sell
-45
Closed -$58.6K – 8193
2019
Q3 		$42K Buy
45
+19
+73% +$21.6K ﹤0.01% 5189
2019
Q2 		$30K Buy
26
+21
+420% +$19.3K ﹤0.01% 5288
2019
Q1 		$4K Buy
5
+3
+150% +$2.72K ﹤0.01% 6603
2018
Q4 		$1K Buy
+2
New +$1.97K ﹤0.01% 6827

Other funds holding APTO

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
AC
Annandale Capital Dallas, Texas $709M AUM 11.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Simplex Trading's APTO Position: Q4 2022 in Review

Simplex Trading sold out of Aptose Biosciences, Inc. (APTO) in Q4 2022, closing a stake of 10 shares — an estimated $2.69K sold.

Simplex Trading first reported a position in APTO in Q4 2018 and held it in 15 quarters. The position peaked at $423K in Q1 2021. 47 funds tracked by Wall St. Rank hold APTO as of Q4 2022.

  • Simplex Trading reported no remaining Aptose Biosciences, Inc. position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 10 Aptose Biosciences, Inc. shares in Q4 2022, an estimated $2.69K.
  • Simplex Trading first reported a position in Aptose Biosciences, Inc. in Q4 2018 and held it in 15 quarters.
  • Simplex Trading's Aptose Biosciences, Inc. position peaked at $423K in Q1 2021.
  • 47 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.